Literature DB >> 330354

Metronidazole in the treatment of chronic proctitis: a controlled trial.

P S Davies, J Rhodes, R V Heatley, E Owen.   

Abstract

Twenty-two patients with chronic proctitis were treated with metronidazole for 28 days in a double-blind controlled trial, but they did not appear to benefit from the drug.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 330354      PMCID： PMC1411704          DOI： 10.1136/gut.18.8.680

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  6 in total

1.  An evaluation of metronidazole in the prophylaxis and treatment of anaerobic infections in surgical patients.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1975-12       Impact factor: 5.790

2.  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES
Journal:  Br Med J       Date:  1964-01-11

3.  Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis.

Authors:  E Monteiro; J Fossey; M Shiner; B S Drasar; A C Allison
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

4.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

5.  Letter: Drug treatment in Crohn's disease.

Authors:  D J Holdstock
Journal:  Lancet       Date:  1975-12-20       Impact factor: 79.321

6.  Letter: Drug treatment in Crohn's disease.

Authors:  R D Montgomery
Journal:  Lancet       Date:  1975-12-06       Impact factor: 79.321
  6 in total
  8 in total

1.  Meta-analysis of the placebo response in ulcerative colitis.

Authors:  Sagar Garud; Alphonso Brown; Adam Cheifetz; Emily B Levitan; Ciaran P Kelly
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 2.  Escherichia coli and ulcerative colitis.

Authors:  D Burke
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

Review 3.  Medical treatment of ulcerative colitis.

Authors:  J E Lennard-Jones
Journal:  Postgrad Med J       Date:  1984-11       Impact factor: 2.401

Review 4.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

Review 5.  Progress and frustration in inflammatory bowel disease.

Authors:  B N Brooke
Journal:  Ann R Coll Surg Engl       Date:  1980-11       Impact factor: 1.891

Review 6.  Current therapy of inflammatory bowel disease in children.

Authors:  Paul A Rufo; Athos Bousvaros
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 7.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 8.  Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.

Authors:  Vipul Jairath; G Y Zou; Claire E Parker; John K MacDonald; Turki AlAmeel; Mohammad Al Beshir; Majid A Almadi; Talal Al-Taweel; Nathan Ss Atkinson; Sujata Biswas; Thomas Chapman; Parambir S Dulai; Mark A Glaire; Daniël R Hoekman; Andreas Koutsoumpas; Elizabeth Minas; Mahmoud H Mosli; Mark Samaan; Reena Khanna; Simon Travis; Geert D'Haens; William J Sandborn; Brian G Feagan
Journal:  Cochrane Database Syst Rev       Date:  2017-09-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.